LANTUS Safety Questions, LANTUS Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about LANTUS. Our extensive database of LANTUS adverse events and LANTUS warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about LANTUS

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




LANTUS Safety Reports

Total LANTUS reports: 1128.
LANTUS FDA safety alerts: No.
Reported deaths: 91    Reported hospitalizations: 445.
Take LANTUS Side Effects Survey or Share Your LANTUS Story. LANTUS Usage.

Showing 1-75 of 1128 Next >

Consumer or non-health professional from UNITED STATES reported LANTUS problem on Feb 07, 2007. Male patient, weighting 124.0 lb, was diagnosed with insulin resistance, asthma, diabetes mellitus and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: convulsion, diabetes mellitus inadequate control, glycosylated haemoglobin increased. LANTUS dosage: unknown. During the same period patient was treated with OPTICLIK, METFORMIN, CLARITIN, SINGULAIR, HUMALOG. Patient recovered.

LANTUS problem was reported by a Consumer or non-health professional from BRAZIL on Feb 05, 2007. Male patient, 65 years of age, weighting 198.4 lb, was diagnosed with blood pressure, pain and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: dyspnoea, hyperglycaemia, hyperhidrosis, hypertension, hypoglycaemia, tremor. LANTUS dosage: unknown. During the same period patient was treated with TACROLIMUS, OMEPRAZOLE, ATENOL, TYLENOL. Patient recovered.

Health Professional from UNITED KINGDOM reported LANTUS problem on Feb 06, 2007. Female patient was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, diabetic ketoacidosis. LANTUS dosage: unknown. During the same period patient was treated with NOVORAPID. Patient recovered.

LANTUS problem was reported by a Health Professional from UNITED KINGDOM on Feb 06, 2007. Female patient was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, diabetic ketoacidosis. LANTUS dosage: unknown. During the same period patient was treated with NOVORAPID. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LANTUS problem on Feb 06, 2007. Female patient, 70 years of age, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, hypnopompic hallucination. LANTUS dosage: unknown. During the same period patient was treated with OPTICLIK, METFORMIN, GLYBURIDE, WARFARIN, GABAPENTIN, FUROSEMIDE, ZOLOFT. Patient recovered.

LANTUS problem was reported by a Consumer or non-health professional from GERMANY on Feb 09, 2007. Male patient was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: dysphonia, neoplasm. LANTUS dosage: unknown. During the same period patient was treated with INSULIN BASAL. Patient recovered.

Physician from BRAZIL reported LANTUS problem on Feb 08, 2007. Female patient, 84 years of age, weighting 154.3 lb, was diagnosed with hypertension and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: dizziness, enteritis, hospitalisation, hyperglycaemia, hyperhidrosis, hypoglycaemia. LANTUS dosage: unknown. During the same period patient was treated with OPTIPEN, LOSARTAN POTASSIUM, SINVASCOR, ALCADIL, NOVORAPID. Patient was hospitalized. Patient recovered.

LANTUS problem was reported by a Physician from BULGARIA on Feb 09, 2007. Female patient, 28 years of age, was diagnosed with diabetes mellitus and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia, vaginal haemorrhage. LANTUS dosage: unknown. During the same period patient was treated with HUMALOG. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LANTUS problem on Feb 07, 2007. Male patient, weighting 124.0 lb, was diagnosed with insulin resistance, asthma, diabetes mellitus and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: convulsion, diabetes mellitus inadequate control, glycosylated haemoglobin increased. LANTUS dosage: unknown. During the same period patient was treated with OPTICLIK, METFORMIN, CLARITIN, SINGULAIR, HUMALOG. Patient recovered.

LANTUS problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 13, 2007. Female patient, 36 years of age, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: diabetic retinopathy, hypertension. LANTUS dosage: unknown. Patient recovered.

Consumer or non-health professional from JAPAN reported LANTUS problem on Feb 12, 2007. Male patient, weighting 176.4 lb, was diagnosed with diabetes mellitus and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, depressed level of consciousness, fall, hypoglycaemia. LANTUS dosage: unknown. During the same period patient was treated with OPTICLIK, HUMALOG. Patient recovered.

LANTUS problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 15, 2007. Female patient, 63 years of age, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: cardiac failure congestive, contusion, dyspnoea, eye swelling, headache, nasopharyngitis, oedema peripheral, sinus headache. LANTUS dosage: unknown. During the same period patient was treated with LEVEMIR, FUROSEMIDE. Patient recovered.

Physician from BELGIUM reported LANTUS problem on Feb 15, 2007. Female patient, 32 years of age, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: premature separation of placenta. LANTUS dosage: unknown. During the same period patient was treated with CARDIOASPIRINE. Patient recovered.

LANTUS problem was reported by a Health Professional from CANADA on Feb 15, 2007. Male patient, 70 years of age, weighting 150.1 lb, was diagnosed with diabetes mellitus, hypertension, erectile dysfunction and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: clostridium difficile colitis, glomerulonephritis acute, hypotension, oedema peripheral, pain in extremity, sleep apnoea syndrome, somnolence, vasculitis. LANTUS dosage: unknown. During the same period patient was treated with ALTACE, VIAGRA, HYTRIN, EQUATE, ADVIL, HUMULIN, GLICLAZIDE, METFORMIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from AUSTRALIA reported LANTUS problem on Feb 19, 2007. Male patient, 76 years of age, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: eye haemorrhage, ocular hyperaemia. LANTUS dosage: unknown. Patient recovered.

LANTUS problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2007. Female patient was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: lung infection, pyrexia. LANTUS dosage: unknown. During the same period patient was treated with OPTICLIK. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported LANTUS problem on Feb 20, 2007. Male patient, weighting 176.4 lb, was diagnosed with diabetes mellitus and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, depressed level of consciousness, fall, hypoglycaemia. LANTUS dosage: unknown. During the same period patient was treated with OPTICLIK, HUMALOG. Patient recovered.

LANTUS problem was reported by a Health Professional from FRANCE on Apr 11, 2006. Female patient, 83 years of age, weighting 169.8 lb, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: diabetes mellitus, ketosis. LANTUS dosage: unknown. During the same period patient was treated with GLUCOPHAGE, NOVONORM. Patient was hospitalized. Patient recovered.

Physician from BRAZIL reported LANTUS problem on Feb 16, 2007. Female patient, 13 years of age, weighting 103.6 lb, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: hyperglycaemia, polydipsia, vomiting. LANTUS dosage: unknown. During the same period patient was treated with AUTOPEN INSULINECTION PEN. Patient recovered.

LANTUS problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 20, 2007. Female patient was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: heart disease congenital. LANTUS dosage: unknown. Patient died on 01/01/2005.

Physician from UNITED STATES reported LANTUS problem on Feb 20, 2007. Male patient, weighting 330.7 lb, was diagnosed with diabetes mellitus and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, coronary artery disease, coronary artery occlusion, injection site haemorrhage, medical device complication, myocardial infarction. LANTUS dosage: unknown. During the same period patient was treated with OPTICLIK, NOVOLOG. Patient recovered.

LANTUS problem was reported by a Health Professional from UNITED STATES on Feb 20, 2007. Female patient, 80 years of age, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, blood glucose increased, colon cancer, decreased appetite, hyponatraemia, ileus, impaired gastric emptying, weight decreased. LANTUS dosage: unknown. During the same period patient was treated with OPTICLIK, AMARYL, DIOVANE, LASIX, POTASSIUM SUPPLEMENT, COLACE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LANTUS problem on Feb 21, 2007. Female patient was diagnosed with diabetes mellitus non-insulin-dependent and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: asthenia, dehydration, heart rate increased, hyperglycaemia. LANTUS dosage: unknown. During the same period patient was treated with NOVOLOG, GLUCOPHAGE. Patient was hospitalized. Patient recovered.

LANTUS problem was reported by a Health Professional from UNITED STATES on Feb 27, 2007. Male patient, 47 years of age, weighting 165.0 lb, was diagnosed with diabetes mellitus and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: suicide attempt. LANTUS dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LANTUS problem on Feb 27, 2007. Female patient was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: lung disorder, pneumonia, pyrexia. LANTUS dosage: unknown. During the same period patient was treated with OPTICLIK. Patient was hospitalized. Patient recovered.

LANTUS problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 24, 2007. Female patient, 77 years of age, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, blood pressure increased, renal artery occlusion, renal function test abnormal. LANTUS dosage: unknown. During the same period patient was treated with COREG, ASPIRIN, ZETIA, ACCUPRIL, LASIX, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.

Physician from BRAZIL reported LANTUS problem on Feb 23, 2007. Female patient, 84 years of age, weighting 154.3 lb, was diagnosed with hypertension, blood cholesterol, abdominal pain upper, diabetes mellitus and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: dizziness, enteritis, hospitalisation, hyperglycaemia, hyperhidrosis, hypoglycaemia. LANTUS dosage: unknown. During the same period patient was treated with OPTIPEN, LOSARTAN POTASSIUM, SINVASCOR, ALCADIL, NOVORAPID. Patient was hospitalized. Patient recovered.

LANTUS problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 28, 2007. Male patient, 85 years of age, was diagnosed with diabetes mellitus insulin-dependent and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, cardiac failure, myocardial infarction. LANTUS dosage: unknown. During the same period patient was treated with OPTICLIK, NOVOLOG, PLAVIX, TOPROL. Patient was hospitalized. Patient died on 12/16/2006.

Consumer or non-health professional from UNITED KINGDOM reported LANTUS problem on Feb 21, 2007. Female patient, weighting 242.5 lb, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: tachycardia. LANTUS dosage: unknown. During the same period patient was treated with PREDNISOLONE, GABAPENTIN, RABEPRAZOLE, IRBESARTAN, AMLODIPINE, BUMETANIDE, ALENDRONIC ACID, ASPIRIN. Patient was hospitalized. Patient recovered.

LANTUS problem was reported by a Consumer or non-health professional from BRAZIL on Feb 26, 2007. Female patient, weighting 125.7 lb, was diagnosed with hypothyroidism, depression, anxiety and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: depression, fatigue, hyperglycaemia, ketoacidosis. LANTUS dosage: unknown. During the same period patient was treated with OPTIPEN, PURAN T, FLUOXETINE, BIOGLIC, RIVOTRIL, METFORMIN. Patient was hospitalized. Patient recovered.

Physician from ITALY reported LANTUS problem on Feb 28, 2007. Male patient was diagnosed with diabetes mellitus and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: alcohol use, device failure, diabetic ketoacidosis, feeding disorder. LANTUS dosage: unknown. Patient recovered.

LANTUS problem was reported by a Physician from BRAZIL on Feb 27, 2007. Female patient, 13 years of age, weighting 103.6 lb, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: hyperglycaemia, polydipsia, vomiting. LANTUS dosage: unknown. During the same period patient was treated with AUTOPEN INSULINECTION PEN. Patient recovered.

Physician from SPAIN reported LANTUS problem on Feb 27, 2007. Male patient, 56 years of age, weighting 231.5 lb, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: leukocytoclastic vasculitis, skin necrosis. LANTUS dosage: unknown. During the same period patient was treated with GLYBURIDE, METFORMIN, ASPIRIN. Patient was hospitalized. Patient recovered.

LANTUS problem was reported by a Pharmacist from UNITED STATES on Mar 02, 2007. Male patient, 70 years of age, was diagnosed with diabetes mellitus and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, tremor, unresponsive to stimuli. LANTUS dosage: unknown. During the same period patient was treated with AVAPRO, AMBIEN, ASPIRIN, COREG, COUMADIN, ALDACTONE, CRESTOR, LASIX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LANTUS problem on Feb 23, 2007. Male patient, 59 years of age, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: condition aggravated, muscle disorder, myasthenia gravis. LANTUS dosage: unknown. During the same period patient was treated with OPTICLIK, PREDNISONE, MESTINON, IMURAN, GLUCOPHAGE. Patient recovered.

LANTUS problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 27, 2007. Female patient, 71 years of age, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: cough, enterocolitis infectious, eye disorder, sinusitis, vision blurred. LANTUS dosage: unknown. During the same period patient was treated with OPTICLIK, AVANDIA, METOPROLOL SUCCINATE, ALTACE, SIMVASTIN, ASPIRIN. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from reported LANTUS problem on Mar 01, 2007. Female patient, 27 years of age, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: meningocele. LANTUS dosage: unknown. During the same period patient was treated with INSULIN ASPART. Patient recovered.

LANTUS problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 27, 2007. Female patient was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: blood ketone body increased, dehydration, hyperglycaemia, influenza. LANTUS dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LANTUS problem on Mar 02, 2007. Female patient, 68 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: cataract, eye irritation. LANTUS dosage: unknown. During the same period patient was treated with OPTICLIK, GLYBURIDE, METFORMIN, ACETYLSALICYLIC ACID SRT, ZYRTEC, BUSPIRONE. Patient recovered.

LANTUS problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 02, 2007. Female patient, 35 years of age, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, vision blurred. LANTUS dosage: unknown. During the same period patient was treated with GLUCOPHAGE, GLUCOTROL. Patient recovered.

Physician from SERBIA AND MONTENEGRO reported LANTUS problem on Mar 02, 2007. Male patient, 53 years of age, weighting 266.8 lb, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: confusional state, encephalitis, melaena. LANTUS dosage: unknown. During the same period patient was treated with OPTIPEN, SIOFOR. Patient was hospitalized. Patient recovered.

LANTUS problem was reported by a Health Professional from UNITED STATES on Feb 28, 2007. Male patient, weighting 99.65 lb, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, diabetic ketoacidosis, lethargy. LANTUS dosage: unknown. During the same period patient was treated with OPTICLIK, NOVOLOG, HYDROCORTISONE, PREVACID, RANITIDINE. Patient was hospitalized. Patient recovered.

Physician from FINLAND reported LANTUS problem on Mar 04, 2007. Female patient, child 2 years of age, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: dizziness, off label use, status epilepticus. LANTUS dosage: unknown. During the same period patient was treated with NOVORAPID, DIFLUCAN. Patient recovered.

LANTUS problem was reported by a Physician from KOREA, REPUBLIC OF on Mar 06, 2007. Male patient, 56 years of age, was diagnosed with diabetes mellitus and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: anorexia, glycosylated haemoglobin increased, weight decreased. LANTUS dosage: unknown. During the same period patient was treated with REPAGLINIDE, GLIMEPIRIDE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LANTUS problem on Mar 06, 2007. Male patient, 70 years of age, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: injection site extravasation. LANTUS dosage: unknown. During the same period patient was treated with OPTICLIK, TORSEMIDE, THEOPHYLLINE, COREG, PREDNISONE, ALTACE, ZOLOFT, VYTORIN. Patient died on 07/28/2006.

LANTUS problem was reported by a Physician from ITALY on Mar 07, 2007. Male patient was diagnosed with diabetes mellitus and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: alcohol use, device malfunction, diabetic ketoacidosis, feeding disorder, ketosis. LANTUS dosage: unknown. Patient recovered.

Physician from BRAZIL reported LANTUS problem on Mar 01, 2007. Female patient, 42 years of age, weighting 127.9 lb, was diagnosed with hyperthyroidism and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: diabetic ketoacidosis, hyperglycaemia, ketosis. LANTUS dosage: unknown. During the same period patient was treated with OPTIPEN, EUTHYROX. Patient recovered.

LANTUS problem was reported by a Consumer or non-health professional from JAPAN on Mar 06, 2007. Male patient, weighting 176.4 lb, was diagnosed with diabetes mellitus and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, depressed level of consciousness, fall, hypoglycaemia. LANTUS dosage: unknown. During the same period patient was treated with OPTICLIK, HUMALOG. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LANTUS problem on Mar 06, 2007. Female patient, 80 years of age, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: aortic stenosis, blood glucose decreased, blood glucose increased, cardiac murmur, dizziness, glycosylated haemoglobin increased, laboratory test abnormal, nervousness. LANTUS dosage: unknown. During the same period patient was treated with OPTICLIK, AVAPRO, CADUET, ASPIRIN, NOVOLOG, TOPROL. Patient recovered.

LANTUS problem was reported by a Consumer or non-health professional from on Mar 08, 2007. Female patient, 27 years of age, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: meningocele. LANTUS dosage: unknown. During the same period patient was treated with INSULIN ASPART. Patient recovered.

Health Professional from GREECE reported LANTUS problem on Mar 12, 2007. Female patient, 38 years of age, weighting 257.9 lb, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: weight increased. LANTUS dosage: unknown. During the same period patient was treated with LISPRO, DIOVANE, CARVEDILOL, GLUCOPHAGE. Patient was hospitalized. Patient recovered.

LANTUS problem was reported by a Consumer or non-health professional from SPAIN on Mar 07, 2007. Male patient, 69 years of age, weighting 168.7 lb, was diagnosed with hypertension and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: effusion, erythema, formication, hyperglycaemia. LANTUS dosage: unknown. During the same period patient was treated with ARADOIS, AMARYL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LANTUS problem on Mar 06, 2007. Female patient, 80 years of age, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: aortic stenosis, blood glucose decreased, blood glucose increased, cardiac murmur, dizziness, glycosylated haemoglobin increased, laboratory test abnormal, nervousness. LANTUS dosage: unknown. During the same period patient was treated with OPTICLIK, AVAPRO, CADUET, ASPIRIN, NOVOLOG, TOPROL. Patient recovered.

LANTUS problem was reported by a Health Professional from UNITED STATES on Mar 09, 2007. Female patient, 14 years of age, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: dyspnoea, heart rate irregular, malaise. LANTUS dosage: unknown. During the same period patient was treated with ALBUTEROL. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LANTUS problem on Mar 05, 2007. Male patient, weighting 295.4 lb, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: weight increased. LANTUS dosage: unknown. During the same period patient was treated with HUMALOG, PROPRANOLOL, ZETIA, ASPIRIN, LEVOCARNITINE, HYDROCHLORTHIAZID, NIACIN. Patient recovered.

LANTUS problem was reported by a Health Professional from GREECE on Mar 14, 2007. Female patient, 38 years of age, weighting 257.9 lb, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: weight increased. LANTUS dosage: unknown. During the same period patient was treated with LISPRO, DIOVAN, CARVEDILOL, GLUCOPHAGE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported LANTUS problem on Mar 12, 2007. Male patient, 68 years of age, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: angle closure glaucoma, retinal haemorrhage. LANTUS dosage: unknown. Patient recovered.

LANTUS problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 13, 2007. Male patient was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: eye haemorrhage. LANTUS dosage: unknown. Patient recovered.

Health Professional from IRELAND reported LANTUS problem on Oct 13, 2006. Male patient, weighting 11.38 lb, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: sepsis, transient tachypnoea of the newborn. LANTUS dosage: unknown. During the same period patient was treated with HUMALOG, NOVORAPID. Patient recovered.

LANTUS problem was reported by a Pharmacist from GERMANY on Dec 11, 2006. Female patient was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: nasal cavity cancer. LANTUS dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LANTUS problem on Mar 12, 2007. Female patient was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: retinal haemorrhage. LANTUS dosage: unknown. Patient recovered.

LANTUS problem was reported by a Physician from UNITED STATES on Mar 14, 2007. Female patient, weighting 170.0 lb, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: balance disorder, blepharitis, blood glucose decreased, blood glucose increased, dry eye, eye infection, fatigue, gait disturbance, gastric disorder. LANTUS dosage: unknown. During the same period patient was treated with OPTICLIK, NOVOLOG, ACTOS, HYDROCODONE, LISINOPRIL, PREMARIN, AMITRIPTYLINE, GABAPENTIN. Patient recovered.

Physician from BRAZIL reported LANTUS problem on Mar 16, 2007. Female patient, 28 years of age, weighting 110.2 lb, was diagnosed with depression and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: dyspnoea, headache, hyperglycaemia, hypoglycaemia, hypoglycaemic unconsciousness, kidney infection, nephrolithiasis, pyrexia, urinary incontinence. LANTUS dosage: unknown. During the same period patient was treated with PURAN T, HUMALOG, TRYPTANOL, PAMELOR, BUSCOPAN. Patient was hospitalized. Patient recovered.

LANTUS problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2007. Male patient, weighting 295.4 lb, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: weight increased. LANTUS dosage: unknown. During the same period patient was treated with HUMALOG, PROPRANOLOL, ZETIA, ASPIRIN, LEVOCARNITINE, HYDROCHLORTHIAZID, NIACIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported LANTUS problem on Mar 14, 2007. Female patient was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, convulsion. LANTUS dosage: unknown. Patient recovered.

LANTUS problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 16, 2007. Female patient, 53 years of age, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: accidental overdose, blood glucose decreased, hyperhidrosis, hypoglycaemic seizure, incoherent, tremor. LANTUS dosage: unknown. During the same period patient was treated with PANCREASE, ADVAIR DISKUS, AZMACORT, TOPAMAX, DEPAKOTE, AMITRIPTYLINE. Patient died on 11/20/2006.

Physician from UNITED KINGDOM reported LANTUS problem on Mar 19, 2007. Male patient, 56 years of age, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: chest discomfort, lower respiratory tract infection. LANTUS dosage: unknown. During the same period patient was treated with NOVORAPID, METFORMIN, AMLODIPINE, LISINOPRIL, ASPIRIN, LANSOPRAZOLE, GAVISCON. Patient was hospitalized. Patient recovered.

LANTUS problem was reported by a Physician from ITALY on Mar 19, 2007. Male patient was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: diabetic ketoacidosis, ketosis. LANTUS dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported LANTUS problem on Mar 20, 2007. Female patient was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: blood ketone body increased, dehydration, hyperglycaemia, influenza. LANTUS dosage: unknown. Patient was hospitalized. Patient recovered.

LANTUS problem was reported by a Physician from GERMANY on Mar 21, 2007. Female patient was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: colon cancer. LANTUS dosage: unknown. Patient recovered.

Consumer or non-health professional from SPAIN reported LANTUS problem on Mar 22, 2007. Male patient, 69 years of age, weighting 168.7 lb, was diagnosed with diabetes mellitus non-insulin-dependent, hypertension and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: effusion, erythema, eye disorder, eye infection, eye inflammation, formication, hyperglycaemia, vascular rupture. LANTUS dosage: unknown. During the same period patient was treated with ARADOIS, AMARYL. Patient recovered.

LANTUS problem was reported by a Consumer or non-health professional from AUSTRALIA on Mar 23, 2007. Male patient, 76 years of age, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: eye haemorrhage, ocular hyperaemia. LANTUS dosage: unknown. Patient recovered.

Physician from SWITZERLAND reported LANTUS problem on Mar 27, 2007. Male patient, 76 years of age, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia, hypoglycaemic seizure, myocardial infarction. LANTUS dosage: unknown. During the same period patient was treated with APIDRA. Patient was hospitalized. Patient recovered.

LANTUS problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 22, 2007. Female patient, 64 years of age, was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, cerebrovascular accident, hemiplegia, visual disturbance. LANTUS dosage: unknown. During the same period patient was treated with GLUCOPHAGE. Patient recovered.

Consumer or non-health professional from RUSSIAN FEDERATION reported LANTUS problem on Mar 29, 2007. Female patient, 70 years of age, was diagnosed with diabetes mellitus and was treated with LANTUS. After drug was administered, patient experienced the following problems/side effects: asthenia, chills, dizziness, loss of consciousness, nausea, vomiting. LANTUS dosage: unknown. Patient recovered.

Showing 1-75 of 1128 Next >

Ask Our Patient Community about LANTUS

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
Paroxetine